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OBJECTIVES We sought to develop and validate a definition of coronary microvascular dysfunction in
women with chest pain and no significant epicardial obstruction based on adenosine-induced
changes in coronary flow velocity (i.e., coronary velocity reserve).
BACKGROUND Chest pain is frequently not caused by fixed obstructive coronary artery disease (CAD) of
large vessels in women. Coronary microvascular dysfunction is an alternative mechanism of
chest pain that is more prevalent in women and is associated with attenuated coronary
volumetric flow augmentation in response to hyperemic stimuli (i.e., abnormal coronary flow
reserve). However, traditional assessment of coronary volumetric flow reserve is time-
consuming and not uniformly available.
METHODS As part of the Women’s Ischemia Syndrome Evaluation (WISE) study, 48 women with chest
pain and normal coronary arteries or minimal coronary luminal irregularities (mean stenosis 5
7%) underwent assessment of coronary blood flow reserve and coronary flow velocity reserve.
Blood flow responses to intracoronary adenosine were measured using intracoronary Doppler
ultrasonography and quantitative angiography.
RESULTS Coronary volumetric flow reserve correlated with coronary velocity reserve (Pearson correla-
tion 5 0.87, p , 0.001). In 29 (60%) women with abnormal coronary microcirculation (mean
coronary flow reserve 5 1.84), adenosine increased coronary velocity by 89% (p , 0.001) but
did not change coronary cross-sectional area. In 19 (40%) women with normal microcircu-
lation (mean flow reserve 5 3.24), adenosine increased coronary velocity and area by 179%
(p , 0.001) and 17% (p , 0.001), respectively. A coronary velocity reserve threshold of 2.24
provided the best balance between sensitivity and specificity (90% and 89%, respectively) for
the diagnosis of microvascular dysfunction. In addition, failure of the epicardial coronary to
dilate at least 9% was found to be a sensitive (79%) and specific (79%) surrogate marker of
microvascular dysfunction.
CONCLUSIONS Coronary flow velocity response to intracoronary adenosine characterizes coronary microvas-
cular function in women with chest pain in the absence of obstructive CAD. Attenuated
epicardial coronary dilation response to adenosine may be a surrogate marker of microvascular
dysfunction in women with chest pain and no obstructive CAD. (J Am Coll Cardiol 1999;
33:1469–75) © 1999 by the American College of Cardiology
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The clinical characteristics of angina pectoris are gender-
specific: 1) angina is the predominant initial manifestation
of coronary artery disease (CAD) in women but not in men,
2) the prevalence rate of angina is greater in women than
men, and 3) chest pain both typical and atypical for angina
in women is frequently not caused by fixed obstructive
epicardial CAD (1–3). An alternative mechanism of recur-
rent chest pain in the absence of significant angiographically
detected CAD is coronary microvascular dysfunction, which
is defined as disordered function of the smaller coronary
resistance vessels (,100 to 200 mm) that play a role in the
regulation of coronary blood flow. Although these mi-
crovessels are usually spared from the gross morphologic
changes of atherosclerosis, they may have abnormal motil-
ity, growth, inflammation and/or permeability resulting in
disordered vascular function.
Microvascular angina is more prevalent in women than in
men and may be manifested by chest pain, an abnormal
stress test and abnormal myocardial perfusion and metabo-
lism in the setting of angiographically normal appearing
coronary arteries (4–8). However, from the clinical perspec-
tive, microvascular angina is a diagnosis of exclusion or one
that is ignored after performance of noninvasive cardiac
testing, coronary angiography and other costly evaluations
of noncardiac chest pain. Often these patients continue to
have pain leading to repeated evaluations. Therefore, early
diagnosis would allow for initiation of appropriate palliative
therapy and decrease utilization of medical resources.
Microvascular angina can be diagnosed in women with-
out obstructive epicardial CAD by demonstrating microvas-
cular dysfunction manifested by an attenuated increase in
coronary flow in response to hyperemic stimuli (i.e., abnor-
mal coronary flow reserve). The traditional definition of
microvascular dysfunction as an explanation for microvas-
cular angina requires that maximal hyperemic stimuli (e.g.,
adenosine) increase coronary volumetric blood flow less than
2.5-fold, which is the lower limit of normal flow reserve in
coronaries free of significant obstructive CAD (9–11).
Coronary volumetric flow reserve is most commonly mea-
sured invasively by quantitative coronary angiography and
intracoronary Doppler ultrasonography, which is time-
consuming, may require off-line analysis and is performed in
few catheterization laboratories. Recent studies, which have
primarily been performed in men, have assessed the func-
tional integrity of the coronary microcirculation by using
intracoronary Doppler ultrasound alone to measure coro-
nary flow velocity responses to adenosine. However, a
definition of microvascular dysfunction based on coronary
flow velocity reserve in women with chest pain in the
absence of obstructive CAD has not been validated.
As part of the pilot phase of the Women’s Ischemia
Syndrome Evaluation (WISE) study, a cohort of women
with chest pain and angiographically normal coronary ar-
teries or minimal coronary luminal irregularities were iden-
tified. They underwent invasive assessment of both coronary
volumetric flow reserve and coronary flow velocity reserve
using quantitative coronary angiography and intracoronary
Doppler ultrasonography (12). The purpose of this report is
to validate a definition of microvascular dysfunction based
on coronary velocity reserve. The results of our study
demonstrate that coronary velocity reserve characterizes
coronary microvascular function in women with chest pain
in the absence of obstructive epicardial CAD, with the
threshold for normal coronary velocity reserve being lower
than that of normal coronary volumetric flow reserve.
METHODS
The WISE study is a National Heart, Lung and Blood
Institute–sponsored four-center study assessing cardiovas-
cular function with state-of-the-art techniques in women
referred for coronary angiography to evaluate chest pain or
suspected ischemia (12). As part of the WISE pilot phase
protocol, the University of Florida (Gainesville, Florida)
and University of Pittsburgh (Pittsburgh, Pennsylvania)
sites used intracoronary Doppler ultrasonography and quan-
titative coronary angiography to evaluate the functional
integrity of the coronary microcirculation in women with
chest pain in the absence of significant fixed obstructive
CAD.
Evaluation of coronary volumetric flow and flow velocity.
Diagnostic coronary angiography was performed using stan-
dard techniques. Women with epicardial coronaries that
were angiographically normal or had minimal luminal ir-
regularities, defined by the absence of $50% diameter
stenoses in all coronary arteries, underwent functional as-
sessment of their coronary microcirculation. In these sub-
jects, a 0.014-in. or 0.018-in., Doppler-tipped guidewire
(Cardiometrics, Mountain View, California) was advanced
through a coronary catheter engaged in the left main or
right coronary artery and positioned in the left anterior
descending artery (n 5 34), left circumflex (n 5 9), first
obtuse marginal (n 5 4) or posterior descending artery (n 5
1). Pulsed-wave Doppler ultrasonography was used to assess
the time-averaged peak coronary flow velocity calculated
on-line over two cardiac cycles through a 2-mm sample
volume at a location approximately 5 mm distal to the tip of
the guidewire.
Quantitative coronary angiographic analysis was per-
formed off-line and masked to all other patient data at the
WISE central angiographic core laboratory (Rhode Island
Hospital, Providence, Rhode Island). Luminal diameter was
measured at the location corresponding to the site of flow
velocity assessment (5 mm distal to the guidewire tip) using
Abbreviations and Acronyms
CAD 5 coronary artery disease
WISE 5 Women’s Ischemia Syndrome Evaluation
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an electronic cine projector-based “crosshair” technique
(Vanguard Instrument Corporation, Melville, New York).
This technique is analogous to electronic calipers built into
the hood of the cine projector, thus removing viewer
parallax, and compares favorably with methods using auto-
mated edge detection (13). In the WISE core laboratory,
the standard deviation of the mean difference in measured
percent stenosis between the two methods was ,8%.
Although multiple views were filmed to determine that no
severe stenoses were present, the cine view used for quan-
titative analysis was chosen to minimize vessel foreshorten-
ing and overlap.
Quantitative angiographic measurements of luminal di-
ameter were used to calculate coronary cross-sectional area.
Coronary volumetric flow was then calculated by the prod-
uct of epicardial coronary cross-sectional area (cm2), a time
constant (60 s/min) and mean coronary flow velocity, which
is one half of the average peak velocity assuming a parabolic
flow velocity profile (14).
Assessment of the functional integrity of the coronary
microcirculation. The functional integrity of the coronary
microcirculation (i.e., vasodilator reserve) was assessed by
measuring coronary volumetric flow and velocity responses
to intracoronary adenosine. Coronary velocity and diameter
were measured at baseline and after a hand-injected intra-
coronary bolus of adenosine (18 mg in left main or 12 mg in
right coronary artery; Adenocard, Fujisawa USA, Deerfield,
Illinois) diluted in 2 ml of normal saline and followed by a
5-ml saline flush. Coronary volumetric flow reserve was
calculated by the ratio of average peak coronary volumetric
flow after adenosine administration to baseline flow. Volu-
metric coronary flow reserves of $2.5 were considered
normal (9–11). Coronary velocity reserve was determined
by the ratio of average peak coronary velocity after adeno-
sine to baseline velocity.
Statistical analysis. The data are summarized as means 6
standard deviations or percent changes when appropriate. P
values of #0.05 are considered statistically significant.
Associations between continuous measures were assessed
using the Pearson correlation coefficient. Significance of
differences between baseline and adenosine measures was
assessed using the Wilcoxon signed rank test. Compari-
sons between subgroups were performed by the Wilcoxon
rank-sum test for continuous measures and by the chi-
squared test or Fisher exact test (when expected cell sizes
were ,5) for discrete measures.
RESULTS
Forty-eight women, 54.2 6 9.7 years of age, with chest pain
and coronary arteries that were angiographically normal or
had minimal luminal irregularities underwent functional
assessment of their coronary microcirculation. Patient char-
acteristics are presented in Table 1. The mean stenosis in
the study artery was 7% (range 0% to 48%), with 38 women
(79%) having 0% stenosis. Of the 30 women who had a
prior noninvasive test to evaluate ischemia, 18 (60%) had
ischemic or indeterminate electrocardiographic responses to
stress; 10 women underwent stress scintigraphy, with 5
(50%) exhibiting perfusion defects.
Coronary volumetric flow and diameter reserve. Adeno-
sine significantly increased coronary volumetric flow by
139.1 6 85.6% from 39.1 6 23.0 to 91.0 6 56.9 ml/min
(p , 0.001). Mean coronary volumetric flow reserve was
2.39 6 0.86; 29 women (60%) had coronary microvascular
dysfunction defined as a volumetric flow reserve ,2.5. In
this subgroup, mean volumetric flow reserve was 1.84 6
0.41 (Table 2). The 19 (40%) women who exhibited normal
coronary microcirculation vasodilator function (i.e., volu-
metric flow reserve $2.5) had a mean volumetric flow
reserve of 3.24 6 0.63. A comparison of clinical character-
Table 1. Baseline Characteristics
n 48
Age in years (mean 6 SD; range) 54.2 6 9.7; 31–71
Race (% White) 88%
Diabetes 13%
Congestive heart failure 0%
Hypertension 48%
Postmenopausal 89%
Dyslipidemia 49%
Lipid-lowering medications 10%
Current hormone replacement therapy 52%
Table 2. Adenosine-Induced Changes in Coronary
Hemodynamics in Women With Normal and Abnormal
Microvascular Function
Normal
Microvascular
Function
(n 5 19)
Abnormal
Microvascular
Function
(n 5 29)
Coronary volumetric flow
(ml/min)
Baseline 35.8 6 17.9 41.3 6 25.9
Adenosine 113.2 6 57.9 76.5 6 52.2
Change (%) 223.6 6 63.2 83.7 6 41.1
p 0.001 , 0.001
Coronary flow velocity
(cm/s)
Baseline 22.5 6 5.1 22.3 6 10.5
Adenosine 61.6 6 15.3 41.7 6 19.3
Change (%) 178.8 6 55.3 89.2 6 37.4
p , 0.001 , 0.001
Epicardial cross-sectional
area (cm2)
Baseline 0.051 6 0.019 0.061 6 0.023
Adenosine 0.060 6 0.025 0.060 6 0.026
Change (%) 17.2 6 14.3 21.7 6 18.7
p , 0.001 NS
Reference standard for normal coronary microvascular function 5 coronary volumet-
ric flow reserve $2.5.
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istics between these groups found that several risk factors,
including history of diabetes and hypertension, were present
more frequently in women with coronary microvascular
dysfunction (Table 3).
The adenosine-induced increase in coronary flow ob-
served in the 19 women with normal coronary microcircu-
lation resulted from significant 178.8 6 55.3% (p , 0.001)
and 17.2 6 14.3% (p , 0.001) adenosine-induced increases
in coronary flow velocity and epicardial cross-sectional area,
respectively. In contrast, the adenosine-induced increase in
coronary volumetric flow seen in the 29 women with
microvascular dysfunction resulted solely from an
adenosine-induced 89.2 6 37.4% (p , 0.001) increase in
coronary velocity, since baseline and postadenosine cross-
sectional areas were not significantly different in this group
(Table 2). Indeed, the lack of adenosine-induced epicardial
dilation, defined as less than 9% dilation in response to an
18-mg bolus of intracoronary adenosine, has a 79% sensi-
tivity and 79% specificity for the diagnosis of microvascular
dysfunction. Therefore, epicardial coronary responses to
adenosine may be a surrogate marker for the diagnosis of
coronary microvascular dysfunction in women with chest
pain in the absence of obstructive CAD.
Subgroup analysis of the 38 women without any angio-
graphic evidence of coronary stenoses in the study artery
demonstrated that, as in the entire study population, 40%
and 60% exhibited normal and abnormal microvascular
function, respectively. The sample size from the pilot phase
of WISE is insufficient for evaluation of clinical predictors
of microvascular dysfunction in this cohort. However, the
relationships observed in Table 3 will be explored in the
final WISE population using the methods validated in the
present study.
Coronary velocity reserve. Coronary microvascular func-
tional integrity was also classified in each woman by the
assessment of her maximum coronary flow velocity response
to adenosine. On average, velocity increased from 22.4 6
8.7 cm/s at baseline to 49.6 6 20.2 cm/s (p , 0.001) during
adenosine. Mean coronary velocity reserve was 2.25 6 0.63.
Figure 1 demonstrates a significant correlation between
coronary velocity reserve and coronary volumetric flow
reserve (Pearson correlation 5 0.87, p , 0.001). However,
examination of the line fitted to this scatterplot indicates
that its slope deviates from identity, with coronary velocity
reserve being less than flow reserve in the majority of
subjects. Interestingly, this observation is primarily due to
the finding that coronary velocity reserve underestimated
volumetric flow reserve in 16 of the 19 women (84%) with
normal microvascular function. In contrast, coronary veloc-
ity reserve underestimated volumetric flow reserve in only 13
of the 29 women (45%) with microvascular dysfunction.
Subgroup analysis of the 38 women without any angio-
graphic evidence of CAD demonstrated similar results
(analysis not shown).
As noted above, microvascular dysfunction, defined by
coronary volumetric flow reserve ,2.5, was present in 29 of
the 48 studied women. Using this classification as the
reference standard, we assessed the accuracy of a range of
coronary velocity reserve thresholds for microvascular dys-
function (Fig. 2). We found that a coronary velocity reserve
threshold of 2.24 provided optimum sensitivity (90%) and
specificity (89%) for the diagnosis of microvascular dysfunc-
tion. This velocity reserve threshold correctly classified
coronary microvascular function in 43 of 48 women (90%).
Specifically, 26 of the 29 (90%) women with microvascular
dysfunction (i.e., coronary volumetric flow reserve ,2.5)
had a coronary velocity reserve of ,2.24, and 17 of 19 (89%)
with normal microvascular function (i.e., coronary volumet-
ric flow reserve $2.5) had a coronary velocity reserve of
$2.24. Of note, this cutpoint also provided nearly optimal
sensitivity and specificity when the analysis was limited to
Table 3. Clinical Characteristics of Women With Normal and
Abnormal Microvascular Function
Normal
Microvascular
Function
(n 5 19)
Abnormal
Microvascular
Function
(n 5 29)
Age in years (mean 6 SD) 52.8 6 10.2 55.1 6 9.5
Diabetes* 0% 21%
Hypertension† 26% 62%
Postmenopausal 89% 89%
Dyslipidemia 33% 61%
Lipid-lowering medications 0% 17%
Current hormone
replacement therapy
50% 54%
*p 5 0.07, †p , 0.05 for comparison of distribution of characteristic between
subgroups. Reference standard for normal coronary microvascular function 5 coro-
nary volumetric flow reserve $2.5.
Figure 1. Relationship between coronary flow velocity reserve
(CVR) and volumetric coronary flow reserve (CFR) in women
with chest pain in the absence of obstructive coronary artery
disease (Pearson correlation 5 0.87, p , 0.001).
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the subgroup of 38 women without angiographic evidence
of coronary atherosclerosis in the study artery.
DISCUSSION
The results of this WISE pilot phase study suggest that the
coronary blood flow velocity response to intracoronary
adenosine characterizes the functional integrity of the cor-
onary microcirculation in women with chest pain and
angiographically normal or only minimally irregular coro-
nary arteries. Coronary velocity reserve can be conveniently
measured by an intracoronary Doppler-tipped guidewire
and correlates significantly with coronary volumetric flow
reserve, which is currently the standard but more labor-
intensive method used to objectively diagnose microvascular
dysfunction. However, we found that coronary velocity
reserve is lower than coronary volumetric flow reserve in
nearly all women with normal microvascular function and is
consistently lower than coronary volumetric flow reserve in
women with microvascular dysfunction. This suggests that
the threshold for normal coronary velocity reserve should be
less than that of coronary volumetric flow reserve. Our
results indicate that microvascular dysfunction is present in
nearly all women with chest pain and insignificant CAD
when coronary flow velocity increases less than 2.24-fold in
response to an intracoronary bolus of adenosine. Further-
more, our data suggest that attenuated adenosine-induced
epicardial coronary dilation may be a surrogate marker for
coronary microvascular dysfunction.
Coronary flow and velocity responses to adenosine. The
functional integrity for flow regulation of the coronary
microcirculation is typically assessed by measuring maximal
changes in coronary volumetric flow in response to vasodi-
lators such as adenosine, which activates adenylate cyclase
and induces cell membrane hyperpolarization in arterial
myocytes present within the coronary microcirculation. As a
result, adenosine causes microvascular dilation and maxi-
mally increases both coronary blood velocity and volumetric
flow. Accordingly, recent studies have used coronary veloc-
ity reserve to assess coronary microvascular function. In
addition, coronary velocity reserve is now commonly used to
evaluate the functional significance of “intermediate” coro-
nary stenoses (15,16). However, the results of these studies,
which suggest that coronary velocity reserves of at least 2.0
are normal, are not applicable to the evaluation of the
functional integrity of the coronary microcirculation in the
cohort of women with chest pain in the absence of obstruc-
tive CAD.
Coronary volumetric flow cannot be directly measured in
patients undergoing coronary angiography. Instead, coro-
nary volumetric flow can be calculated by the use of
validated equations that incorporate measurements of mean
coronary flow velocity and epicardial cross-sectional area
(14,17). Adenosine-induced changes in coronary flow ve-
locity are expected to approximate adenosine-induced
changes in coronary volumetric blood flow only if epicardial
coronary caliber remains constant. However, adenosine’s
vasodilatory effect is not limited to the coronary microcir-
culation; when administered in an epicardial coronary seg-
ment, adenosine induces endothelium-independent vasodi-
lation distal to the site of infusion (18,19). In addition,
adenosine-induced increases in coronary blood flow result in
endothelium-dependent dilation of epicardial coronaries
with intact endothelial function (18,19). Therefore, coro-
nary volumetric flow and velocity responses to adenosine
may not be equivalent. Indeed, although coronary velocity
responses to adenosine correlated significantly with volu-
metric flow responses in our study, the threshold for velocity
reserve that provided the best combination of sensitivity and
specificity for the diagnosis of microvascular dysfunction
(i.e., 2.24) was lower than the threshold for normal coronary
volumetric flow reserve (i.e., 2.5).
Epicardial coronary artery responses to adenosine. The
finding that mean coronary volumetric flow reserve is
generally greater than mean coronary velocity reserve is
consistent with those of a previous report (20) and may be
explained by our observation that adenosine increases both
of the independent variables in the equation used to
calculate coronary flow: epicardial coronary cross-sectional
area and coronary flow velocity. Interestingly, we found
distinct large vessel responses to adenosine: 1) dilation of
epicardial coronaries in women with normal microvascular
flow reserve function, and 2) lack of epicardial dilation in
those with microvascular dysfunction. Because adenosine-
induced epicardial coronary dilation results partly from
endothelium-dependent flow-mediated dilation, it appears
that women with chest pain and microvascular dysfunction
may have endothelial dysfunction in their epicardial coro-
naries. This observation is supported by previous reports
Figure 2. Sensitivities and specificities of different thresholds of
coronary velocity reserve for diagnosing microvascular dysfunction.
Solid line 5 sensitivity; dashed line 5 specificity.
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suggesting that microvascular dysfunction is caused by
abnormal endothelial function in the coronary microvascu-
lature (21–23). Alternatively, our findings may be explained
by the attenuated adenosine-induced increase in coronary
flow in those with microvascular dysfunction because a
suboptimal increase in flow for any reason may provide an
inadequate increase in shear stress that is sensed by the
endothelial cell to result in epicardial coronary dilation (24).
The association identified between epicardial coronary
dilation and coronary flow velocity augmentation in re-
sponse to an intracoronary bolus of adenosine suggests that
the conductance coronary response to adenosine may be
used as a low risk inexpensive method to assess microvas-
cular function in women without obstructive CAD. Indeed,
the sensitivity and specificity of attenuated epicardial coro-
nary dilation in response to adenosine (i.e., ,9% diameter
increase) are both 79% for the diagnosis of microvascular
dysfunction. However, further validation studies are re-
quired before this observation can be applied to the large
cohort of women with chest pain in the absence of obstruc-
tive CAD.
Study limitations. Our study is limited by the use of an
intracoronary bolus of adenosine as the hyperemic stimulus
to assess coronary reserve and its reliance on intracoronary
Doppler ultrasonography and quantitative coronary angiog-
raphy to estimate coronary blood flow. However, we chose
intracoronary adenosine instead of intravenous adenosine to
avoid confounding effects associated with intravenous use
such as transient lowering of systemic blood pressure and
changes in heart rate, both of which can decrease coronary
perfusion pressure and alter coronary flow independent of
the functional integrity of the coronary microcirculation. In
addition, direct measurement of intracoronary blood flow is
impractical in humans. Therefore, we used a validated
method (14) to indirectly quantify coronary blood flow
using an intracoronary Doppler-tipped guidewire because of
its ability to assess coronary blood flow when used in
conjunction with quantitative coronary angiography and
because of its low profile which is not expected to impede
coronary flow.
This study developed and validated a definition of coro-
nary microvascular dysfunction in women with chest pain
and no obstructive CAD based on coronary flow velocity
reserve. It also identified a high (60%) prevalence of micro-
vascular dysfunction in this cohort. However, we may have
overestimated the role of this disease entity because 1) the
relationship between microvascular dysfunction and chest
pain is uncertain (25), 2) no association has been demon-
strated between microvascular dysfunction and myocardial
ischemia, and 3) the limited sample size of this WISE pilot
study does not allow us to control for clinical variables that
may influence coronary reserve including atherosclerotic risk
factors, blood pressure and heart rate. Nevertheless, the
methods developed by the present study will be used to
assess the prevalence of microvascular dysfunction and its
relationship to myocardial ischemia and clinical factors in
the final WISE cohort.
Conclusions. In summary, chest pain in women with
coronary arteries that are angiographically normal or have
minimal luminal irregularities is frequently attributed to a
“noncardiac” etiology. Although microvascular dysfunction
in the absence of epicardial CAD may be associated with a
relative freedom from death or myocardial infarction
(26,27), it may result in debilitating symptoms, frequent
hospitalizations, extensive evaluations and loss of produc-
tivity and wages. Therefore, early diagnosis of microvascular
dysfunction may facilitate initiation of appropriate therapy
and may decrease health care costs in women with chest
pain. Our results indicate that the functional integrity of the
coronary microcirculation can be accurately assessed during
coronary angiography by measuring coronary flow velocity
responses to an intracoronary bolus of adenosine. Although
this diagnostic approach requires the use of an intracoronary
Doppler-tipped guidewire, it is simpler and less time-
consuming than the traditional approach, which necessitates
both intracoronary Doppler ultrasonography and quantita-
tive coronary angiography to calculate coronary volumetric
flow reserve. In addition, we observed that changes in
epicardial coronary diameter in response to adenosine may
provide an even less invasive assessment of microvascular
function. As a result, women with chest pain not attributed
to CAD may undergo a rapid diagnostic evaluation to
accurately assess the functional integrity of their coronary
microcirculation and to diagnose the etiology of their
symptoms. These diagnostic approaches are being used in
the second phase of the WISE study to further characterize
the pathophysiologic mechanisms, ischemic and clinical
sequelae and associated demographics of chest pain in a
large cohort of women.
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